SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CSPC Begins Phase I/II Trial of SYS6062 in China

CSPC has begun a Phase I/II trial of SYS6062 for advanced solid tumors in China.

Related stories